Management of Degenerative Cervical Myelopathy

Featuring: Michael G. Fehlings, MD, PhD, FRCSC, Paul M. Arnold, MD

Disclosures:

Arnold, Paul M.: Board of Directors: AANS/CNS Joint Section on Neurotrauma (Nonfinancial), CSRS (Nonfinancial), LSRS (Nonfinancial), SpineEx (1%); Consulting: Asterias (A, Outside 12-Month Requirement), Cerapedics (C), Medtronic (B), Spine Wave (B); Research Support (Staff and/or materials): Evoke Medical, LLC (40%, Paid directly to institution/employer).

Fehlings, Michael G.: Consulting: Fortuna Fix (B).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+